AFG
CLVS

Allegheny Financial Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Allegheny Financial Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,950
Closed -$16K – 175
2022
Q3 		$16K Sell
13,950
-474
-3% -$739 0.01% 159
2022
Q2 		$26K Hold
14,424
– – 0.01% 164
2022
Q1 		$29K Sell
14,424
-675
-4% -$1.33K 0.01% 160
2021
Q4 		$41K Sell
15,099
-750
-5% -$2.77K 0.02% 158
2021
Q3 		$71K Hold
15,849
– – 0.03% 148
2021
Q2 		$92K Hold
15,849
– – 0.04% 150
2021
Q1 		$111K Hold
15,849
– – 0.08% 97
2020
Q4 		$76K Buy
+15,849
New +$80.2K 0.04% 126

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Allegheny Financial Group's CLVS Position: Q4 2022 in Review

Allegheny Financial Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 13,950 shares — an estimated $16K sold.

Allegheny Financial Group first reported a position in CLVS in Q4 2020 and held it in 8 quarters. The position peaked at $111K in Q1 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Allegheny Financial Group reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Allegheny Financial Group sold 13,950 Clovis Oncology, Inc. shares in Q4 2022, an estimated $16K.
  • Allegheny Financial Group first reported a position in Clovis Oncology, Inc. in Q4 2020 and held it in 8 quarters.
  • Allegheny Financial Group's Clovis Oncology, Inc. position peaked at $111K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Allegheny Financial Group's 13F filing for Q4 2022, filed 8 Feb 2023.